Iambic Therapeutics
Iambic Therapeutics

Iambic Therapeutics

AI-driven drug discovery company developing novel medicines for unmet patient needs.

2019Active151San Diego, United States

Check the tech stack behind iambic.ai. Find a founder email at iambic.ai.

We may earn a commission from links on this Iambic Therapeutics profile. That does not change the facts we publish.

About

Iambic Therapeutics is a clinical-stage life science and technology company that develops novel medicines using its AI-driven discovery and development platform. Founded in 2019, the company integrates artificial intelligence with physics principles to tackle complex molecular design challenges, aiming to accelerate drug discovery timelines and reduce development risks for pharmaceutical and biotech organizations. Teams look it up for Biotech, HealthTech, Drug Discovery.

Frequently asked

What does Iambic Therapeutics do?

Iambic Therapeutics is a Biotech company that offers Platform. Teams look it up for HealthTech, Drug Discovery, AI-Driven Drug Discovery. It is based in San Diego, United States and was founded in 2019. Public records show about 151 people and $50M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.

How much funding has Iambic Therapeutics raised?

Iambic Therapeutics has raised a total of $50M in funding. The most recent round on record is Series B Extension.

Where is Iambic Therapeutics headquartered?

Iambic Therapeutics is headquartered in San Diego, United States.

When was Iambic Therapeutics founded?

Iambic Therapeutics was founded in 2019.

What industry does Iambic Therapeutics operate in?

Iambic Therapeutics operates in Biotech, HealthTech, Drug Discovery, AI-Driven Drug Discovery, Foundation Model.

How many employees does Iambic Therapeutics have?

Iambic Therapeutics has approximately 151 people on record.

Scores
Measured, not editorial
Ahrefs DR
48/100

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Agent Readiness
31/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Add first review